FCN3 and acute myeloid leukemia: As in the case of ficolin-2, the median ficolin-3 serum concentration was markedly higher for AML patients (33.6 μg/ml) compared with controls (19.6 μg/ml, p < 0.000001, Mann–Whitney U-test).